US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

These cells are located in the spinal cord. Because the muscles cannot respond to signals from the nerves, they atrophy — weaken and shrink — from inactivity. One in every 6,000 babies is born with ...

Enea Bastianini dominates the Thailand sprint, as Martin takes a crucial second ahead of Bagnaia to increase his championship lead to 22 points. Marc Marquez is a distant fourth. Bastianini ...

Ducati completed a top-eight lockout in Thailand as Enea Bastiaini dominated the Sprint Race. Enea Bastianini returns to winning ways in MotoGP as he dominates the Thai Grand Prix Sprint Race. This is ...

Sprint is now T-Mobile! The two companies merged back in 2020. Visit our T-Mobile Review to learn about the carrier’s 55+ plans. If you're on the fence about T-Mobile, check out some top-rated ...

Julia Hawkins, an age group world record-holder in the sprints, died on Tuesday, October 22 in Baton Rouge, Louisiana. The 100-meter star, known as “Hurricane” among her peers, was 108 ...

Three months after its debut, Netflix’s popular track and field series SPRINT is set to return with a highly anticipated second season. Premiering on Nov. 13, the new season will give fans an ...

At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial shows. Rates of treatment response and depression remission were three times ...

TUESDAY, Oct. 22, 2024 (HealthDay News) -- At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial shows. Rates of treatment response ...

Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. Since the passing of ...